Fieldpoint Private Securities’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$15K Sell
219
-115
-34% -$8.54K ﹤0.01% 656
2022
Q1
$26K Buy
334
+127
+61% +$9.13K 0.01% 773
2021
Q4
$16K Sell
207
-1,150
-85% -$84.5K ﹤0.01% 939
2021
Q3
$100K Hold
1,357
0.02% 414
2021
Q2
$104K Sell
1,357
-5,394
-80% -$361K 0.02% 409
2021
Q1
$502K Buy
6,751
+1,316
+24% +$99.9K 0.12% 193
2020
Q4
$396K Buy
5,435
+114
+2% +$8.05K 0.09% 215
2020
Q3
$354K Buy
5,321
+1,427
+37% +$90.3K 0.1% 199
2020
Q2
$222K Buy
+3,894
New +$191K 0.07% 226

Other funds holding HOLX

Fieldpoint Private Securities's HOLX Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Hologic (HOLX) stake by 34% in Q2 2022, selling an estimated $8.54K and leaving 219 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #656.

Fieldpoint Private Securities first reported a position in HOLX in Q2 2020 and has held it in 9 quarters since. The position peaked at $502K in Q1 2021. 695 funds tracked by Wall St. Rank hold HOLX as of Q2 2022.

  • Fieldpoint Private Securities held 219 shares of Hologic worth $15K as of Q2 2022.
  • Fieldpoint Private Securities sold 115 Hologic shares in Q2 2022, an estimated $8.54K.
  • Hologic made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #656 holding.
  • Fieldpoint Private Securities first reported a position in Hologic in Q2 2020 and has held it in 9 quarters since.
  • Fieldpoint Private Securities's Hologic position peaked at $502K in Q1 2021.
  • 695 funds tracked by Wall St. Rank held Hologic as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.